Prasol Chemicals IPO Allotment Status

Issue closes

TBA

Allotment (expected)

TBA

Listing

TBA

Registrar

TBA

How to check allotment

  1. 1Open your registrar's IPO allotment page and select Prasol Chemicals.
  2. 2Enter your PAN, application number, or DP/Client ID.
  3. 3If allotted, shares are credited to your demat account before the listing date; if not, your blocked UPI/ASBA amount is released automatically.
Prasol Chemicals GMP today →Subscription status →All IPOs →

How to increase your allotment chances

Allotment follows published SEBI rules — a lottery in one category, proportionate in another. Eight things that change your position.

01

Know which bucket you are in

Retail (up to ₹2 lakh) is allotted by lottery when oversubscribed. S-HNI and B-HNI are allotted proportionately. The same strategy cannot work in both.

02

In retail, more applications beat one big application

Five one-lot applications from five different PANs are five lottery tickets. One application for five lots is one ticket. The hard limit: one application per PAN — a second on the same PAN gets them all rejected.

The HUF account, reading live category data, reserved quotas and the rejection checklist. Free account, 30 seconds.

Read the full allotment guide →

Frequently asked questions

When is Prasol Chemicals IPO allotment?

Prasol Chemicals IPO allotment is yet to be announced. Allotment is typically finalized one working day after the issue closes.

How do I check Prasol Chemicals IPO allotment status?

Check on the registrar's IPO status page using your PAN, application number or DP/Client ID — or on the BSE/NSE IPO allotment pages. If allotted, shares are credited to your demat before listing; if not, the blocked amount is released.

Why didn't I get allotment despite applying?

When the retail portion is oversubscribed, allotment happens by computerized lottery — at high oversubscription most applicants receive no shares regardless of bid size. Applying at cut-off with a single lot has the same lottery odds as multiple lots in heavy oversubscription.

Dates are as announced in the offer documents and may change. Research platform — not investment advice.